News

April 22, 2010 — An improved formulation of epoprostenol for the treatment of primary pulmonary arterial hypertension (PAH) and pulmonary hypertension is now commercially available.

April 19, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a generic version of metoprolol succinate extended-release tablets. The beta-blocker is used to treat angina, heart...

April 14, 2010 – An antibacterial wrap for implanted pacemakers and defibrillators released this week is designed to provide protection against infections. The AigisRx Flat delivers the...

April 7, 2010 – A medical manufacturer pleaded guilty Monday to criminal violations for improper reporting of short-circuit failures of three models of its implantable cardioverter defibrillators...

April 7, 2010 – The U.S. Food and Drug Administration (FDA) recently sent a warning letter to Edwards Lifesciences Corp. for late reporting of adverse events with its medical devices.

March 31, 2010 — Boston Scientific Corp. recently announced that it has stopped shipment and is retrieving field inventory of all its implantable cardioverter defibrillators (ICDs) and cardiac...

March 30, 2010 – To accelerate development, incubating and commercializing new cardiovascular technology, the Global Cardiovascular Innovation Center (GCIC) plans to open a new building in May. It...

March 24, 2010 – Enrollment began this week in the CITADEL, which is the second of two large-scale, prospective, multicenter studies comparing implantable electrophysiology device infection rates...

March 23, 2010 – The U.S. Food and Drug Administration (FDA) recently added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and healthcare professionals...

March 23, 2010 – The FDA granted approval for diltiazem hydrochloride extended-release tablets to treat hypertension, which is the generic equivalent to Biovail Laboratories International SRL's...

March 16, 2010 — Lowering blood pressure to normal levels — below currently recommended levels — did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events...

Organizers of the 2010 ACC Annual Scientific Session, March 13–16 in Atlanta, recently highlighted some of the changes to this year’s program.

On Saturday, March 13, the ACC is hosting the...

March 3, 2010 – Pharmaceutical companies will struggle to profit from the cardiovascular disease (CVD) market over the next decade despite growing drug usage, according to new market research from...

February 12, 2010 - After the U.S. FDA announced it is launching a program designed to reduce unnecessary medical radiation exposure with a focus on computed tomography, nuclear medicine and...

February 11, 2010 – Former president Bill Clinton received two coronary stents today after being admitted to the hospital with chest pain.

February 9, 2010 – The FDA approved CRESTOR (rosuvastatin calcium) to reduce the risk of stroke, myocardial infarction and arterial revascularization procedures in individuals without clinically...

February 9, 2010 – Researchers are developing technology that they hope will one day prevent thrombus formation on cardiovascular devices without the use of anticoagulation drugs.

January 21, 2010 – A new minimally invasive therapy using radiofrequency ablation to short-circuit nerves in the kidney arteries shows promise in treating uncontrolled hypertension. The research...

January 21, 2010 - A recent study found generic epoprostenol is a safe and effective therapy alternative to brand name Flolan for patients suffering from pulmonary arterial hypertension (PAH).

January 11, 2010 – A hypertension drug using a combination of telmisartan/amlodipine, which requires less-frequent dosing than Novartis's Diovan/Tareg (valsartan), may earn 30 percent patient...